Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
FLGT compared with AKBA: revenue, margins and what each company keeps, and the suppliers and customers both name
FLGT
Fulgent Genetics, Inc.
Change
Mkt cap
Revenue
Revenue
AKBA
Akebia Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
FLGT
Fulgent Genetics, Inc.
vs
AKBA
Akebia Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
FLGT, solid
AKBA, dashed
FLGT
Fulgent Genetics, Inc.
Change
23.79
▲
+27.52%
· post 23.79
Mkt cap
$663.3M
Revenue
$90M
Q3 FY26
Revenue
$323M
FY25
AKBA
Akebia Therapeutics, Inc.
Change
0.40
▼
−6.02%
· post 0.40
Closed
Nov 6 '26
Mkt cap
$111.4M
Revenue
$37M
Q3 FY26
Revenue
$236M
FY25
vs
Compare
Closed
Nov 6 '26
FLGT
Fulgent Genetics, Inc.
vs
AKBA
Akebia Therapeutics, Inc.
23.79
▲
+27.52%
post 23.79
Price
0.40
▼
−6.02%
post 0.40
$663.3M
Mkt cap
$111.4M
Q3 FY26
$90M
Revenue
$37M
Q3 FY26
FY25
$323M
Revenue
$236M
FY25
Change
Change
FLGT
23.79
▲
+27.52%
vs
AKBA
0.40
▼
−6.02%
Closed
Nov 6 '26